Liver fibrosis and ethanol: role of the transcription factor, Egr-1
Liver fibrosis and ethanol: role of the transcription factor, Egr-1
批准号:
8585770
负责人:
MICHELE T PRITCHARD
金额:
$21.14万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-11-20 至 2014-07-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Ethanol-induced hepatic fibrosis is a severe form of liver disease. Although great strides have been made in
understanding the mechanisms by which fibrosis is established and how it resolves, these discoveries have
not yet lead to improved therapeutic strategies. Egr-1 is a transcription factor that regulates a broad array of
genes involved in inflammation and the wound-healing response. Egr-1 is a critical modulator of ethanolinduced
fatty liver and acute hepatic inflammation in mice. Due to the ability of Egr-1 to regulate genes that
modulate fibrosis, we hypothesize that Egr-1 is an important contributor to liver fibrosis after toxin-mediated
liver injury. Indeed, recently published work completed during the K99 portion of this award revealed that
carbon tetrachloride (CCI4)-induced liver fibrosis is enhanced in mice deficient in Egr-1. Enhanced fibrosis
was associated with reduced hepatoprotection, more severe liver injury and a delay in hepatocyte entrance
into and progression through the cell cycle in egr-1-/- mice after acute CCI4 exposure. Activation of the oval
cell response in egr-1-/- mice after chronic CCW exposure is consistent with these findings. Collectively, our
studies suggest novel roles for Egr-1 as a critical modulator the liver's response to hepatotoxins and the
fibrogenic process.
Ethanol feeding to mice produces limited fibrosis necessitating the use of hepatotoxicants such as CCi4 to
explore mechanisms of fibrosis. To better understand the effects of ethanol exposure on fibrogenesis, we
developed a new model with which we can 'accelerate' fibrosis using low-level ethanol (2% v/v ethanol for 5
days to 2 weeks) in combination with acute or chronic CCW exposure. Importantly, CYP2E1, the enzyme
required for CCW bioactivation and induced in liver after chronic ethanol exposure, is not different between
control and ethanol-fed mice exposed to this dose of ethanol. Using this model, as well as primary hepatic
stellate cell cultures, we will continue to dissect the molecular mechanisms by which Egr-1 contributes to
fibrosis through completion of the three Specific Aims as originally described.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Liver fibrosis and ethanol: role of the transcription factor, Egr-1
-
批准号:8508747
-
项目类别:
-
资助金额:$22.27万
-
财政年份:2012
-
负责人:MICHELE T PRITCHARD
-
依托单位:
Liver fibrosis and ethanol: role of the transcription factor, Egr-1
-
批准号:8329621
-
项目类别:
-
资助金额:$3.76万
-
财政年份:2011
-
负责人:MICHELE T PRITCHARD
-
依托单位:
Liver fibrosis and ethanol: role of the transcription factor, Egr-1
-
批准号:8263799
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2011
-
负责人:MICHELE T PRITCHARD
-
依托单位:
Liver fibrosis and ethanol: role of the transcription factor, Egr-1
-
批准号:7571976
-
项目类别:
-
资助金额:$10.75万
-
财政年份:2009
-
负责人:MICHELE T PRITCHARD
-
依托单位:
Animal Core
-
批准号:7674880
-
项目类别:
-
资助金额:$3.69万
-
财政年份:2009
-
负责人:MICHELE T PRITCHARD
-
依托单位:
Egr-1 and EtOH-induced hepatic leukocyte recruitment
-
批准号:6994296
-
项目类别:
-
资助金额:$4.04万
-
财政年份:2005
-
负责人:MICHELE T PRITCHARD
-
依托单位:
Egr-1 and EtOH-induced hepatic leukocyte recruitment
-
批准号:7134300
-
项目类别:
-
资助金额:$5.04万
-
财政年份:2005
-
负责人:MICHELE T PRITCHARD
-
依托单位:
Egr-1 and EtOH-induced hepatic leukocyte recruitment
-
批准号:7281088
-
项目类别:
-
资助金额:$0.79万
-
财政年份:2005
-
负责人:MICHELE T PRITCHARD
-
依托单位:
Animal Core
-
批准号:8379778
-
项目类别:
-
资助金额:$4.46万
-
财政年份:--
-
负责人:MICHELE T PRITCHARD
-
依托单位:
Animal Core
-
批准号:8318713
-
项目类别:
-
资助金额:$3.72万
-
财政年份:--
-
负责人:MICHELE T PRITCHARD
-
依托单位:
Animal Core
-
批准号:8137303
-
项目类别:
-
资助金额:$3.76万
-
财政年份:--
-
负责人:MICHELE T PRITCHARD
-
依托单位:
Animal Core
-
批准号:8529399
-
项目类别:
-
资助金额:$3.32万
-
财政年份:--
-
负责人:MICHELE T PRITCHARD
-
依托单位:
国内基金
海外基金
登录
查看更多内容
间皮细胞衰老在腹膜透析后腹膜适应不良修复和纤维化发病中的作用及机制研究
-
批准号:82370743
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:姜娜
-
依托单位:
SENP1调控巨噬细胞极性参与老年心肌纤维化的作用及机制
-
批准号:82371584
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:薛松
-
依托单位:
巨噬细胞通过Piezo1感知组织硬度限制肝脏纤维化的作用机制研究
-
批准号:82371760
-
项目类别:面上项目
-
资助金额:52.00万元
-
批准年份:2023
-
负责人:王静
-
依托单位:
犬尿氨酸酶KYNU参与非酒精性脂肪肝进展为肝纤维化的作用和机制研究
-
批准号:82370874
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:刘才智
-
依托单位:
Hippo信号通路调控肝星状细胞活化机制研究
-
批准号:32070789
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:葛高翔
-
依托单位:
错义突变介导的TGR5持续活化与功能丧失在胆管纤维化与结石形成中的作用及机制研究
-
批准号:81960125
-
项目类别:地区科学基金项目
-
资助金额:30.0万元
-
批准年份:2019
-
负责人:赵礼金
-
依托单位:
脱硫弧菌通过肠肝轴诱导肝纤维化的机制研究
-
批准号:31970746
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2019
-
负责人:耿燕
-
依托单位:
Krüppel样因子4在特发性肺纤维化胸膜间皮细胞-肌成纤维细胞表型转化中的作用和机制的研究
-
批准号:81141001
-
项目类别:专项基金项目
-
资助金额:10.0万元
-
批准年份:2011
-
负责人:林连君
-
依托单位:
尾加压素II在心房纤维化中的作用及机制
-
批准号:81000052
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2010
-
负责人:史力斌
-
依托单位:
黄芪当归合剂有效组分抗氧化应激作用的细胞信号转导调控机制研究
-
批准号:81041001
-
项目类别:专项基金项目
-
资助金额:10.0万元
-
批准年份:2010
-
负责人:王玉
-
依托单位: